Skip to main content
VBIO
NASDAQ Life Sciences

Valion Bio Stockholders Grant Board 1-for-2 to 1-for-12 Reverse Split Authority

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.51
Mkt Cap
$1.14M
52W Low
$0.472
52W High
$67.5
52W Position info
8.2% above low
Off High info
99% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

VBIO is trading near its 52-week low of $0.472 (8.2% above the low) on light trading volume (0.1× avg).

Summary

Valion Bio shareholders approved giving the board authority to reverse-split the stock anywhere from 1-for-2 to 1-for-12 within twelve months, and approved 272,000 additional shares for the 2021 equity plan. The vote clears the way for another split just months after the August 1-for-25.


Key Events · Corporate Governance and Compliance · VBIO

  • Board Wins Reverse Split Authority

    Stockholders approved discretionary authority for the board to amend the charter for a reverse split of not less than 1-for-2 and not greater than 1-for-12, exercisable any time within twelve months without further stockholder approval.

  • Equity Plan Reserve Raised 272,000 Shares

    The 2021 Equity Incentive Plan reserve was increased by 272,000 shares, effective on stockholder approval; no other plan terms changed.

  • Split Vote Draws Meaningful Opposition

    The reverse-split proposal passed 681,523 to 444,153, with 9 abstentions — roughly 39% of votes cast were against it.

  • Second Split in Under Three Months

    Follows the 1-for-25 reverse split effective August 31, 2026, which was itself aimed at regaining Nasdaq's $1.00 minimum bid price.


Analysis · VBIO · Life Sciences

Valion Bio now has a twelve-month window to execute a reverse split at a ratio of its choosing, without another shareholder vote. That matters because the company is fighting to hold its Nasdaq listing after a 1-for-25 split in August 2026, and it is down to roughly $2.1M in cash with going-concern doubt already on the record. A second split within months would be a mechanical fix to the $1.00 bid price, not a fix to the business — and it comes alongside a 272,000-share increase to the equity plan reserve, which adds to the share overhang. The 52.22% turnout and the 444,153 votes against the split authority show a meaningful slice of holders are not on board.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VBIO was trading at $0.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1M. The 52-week trading range was $0.47 to $67.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VBIO - Latest Insights

VBIO
Nov 05, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.502
Real-time Price: $0.551116 info
Change: +$0.049116 (+10%) info
Market Cap: $1.14M info
VBIO
Nov 02, 2026, 7:50 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.585
Real-time Price: $0.551116 info
Change: -$0.033884 (-6%) info
Market Cap: $1.14M info
VBIO
Oct 30, 2026, 7:50 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.6373
Real-time Price: $0.551116 info
Change: -$0.086184 (-14%) info
Market Cap: $1.14M info
VBIO
Oct 29, 2026, 7:45 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6758
Real-time Price: $0.551116 info
Change: -$0.124684 (-18%) info
Market Cap: $1.14M info
VBIO
Oct 27, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.765
Real-time Price: $0.551116 info
Change: -$0.213884 (-28%) info
Market Cap: $1.14M info